Amarin Corporation plc. is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA® (icosapent ethyl), is available by prescription in certain countries, including in the United States. For more information about Amarin, visit www.amarincorp.com. For more information about VASCEPA, including how to get samples, copay cards and more, visit www.vascepahcp.com. For full prescribing information, please see PDF below.